Journal of Semnan University of Medical Sciences
Determination of serum paraoxonase phenotype distribution by double-substrate method in patients with coronary artery disease
Authors
Abstract
Introduction: Considering the high incidence of patients with coronary artery disease (CAD) in the Iranian population and a preventive role of serum paraoxonase (PON1) in development of CAD, the present study was designed to determine the distribution of PON1 phenotypes in patients with CAD. Materials and Methods: A total of 61 patients with coronary stenosis of 70% were included in this study. Paraoxonase and arylesterase activities were measured using paraoxon and phenylacetate as substrate, respectively. Phenotyping of the PON1 Q192R polymorphism was determined by calculating the ratio of salt-stimulated paraoxonase activity to arylesterase activity (double-substrate method). Results: Patients with stenosis of 70% at ratios of 2.42 and 5.91. In patients with stenosis of 70% were 48%, 41% and 11%, respectively. Conclusions: Based on his study and other studies conducted in Iran, it can be concluded that in the Iranian population there is no statistically difference in phenotype distribution of PON1 between patients with CAD (with severe stenosis or mild stenosis) and healthy individuals.
Copyright
© 2011, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.
Similar Articles
Paraoxonase and Arylesterase activities of human serum paraoxonase in coronary artery disease
Mahrooz A, Nori M, Rashidi M, AslanAbadi N, Ghojegh D, et al. Paraoxonase and Arylesterase activities of human serum paraoxonase in coronary artery disease. koomesh. 2008;10(1):e152212. doi:
Association Assessment of Paraoxonase 1 Gene Polymorphism with Coronary Artery Disease in Golestan, Iran
Abdolahpour S, Bakhshandeh A, Farazmandfar T, Rayatnavaz M, Shahbazi M. Association Assessment of Paraoxonase 1 Gene Polymorphism with Coronary Artery Disease in Golestan, Iran. Int Cardiovasc Res J. 2017;11(4):e61212. doi:
Investigation of PCSK9 Gene Polymorphisms in Two Iranian Ethnic Groups with Coronary Artery Disease in Fars Province
Zibaeenezhad MJ, Yavarian M, Fathzadeh M, Heydari Kamrodi M, Fattahi Mofrad M, et al. Investigation of PCSK9 Gene Polymorphisms in Two Iranian Ethnic Groups with Coronary Artery Disease in Fars Province. Int Cardiovasc Res J. 2020;14(2):e100140. doi:
Association Between Paraoxonase1 (Q192R and L55M) Gene Polymorphisms and Risk of Breast Cancer: A Meta-analysis of 12 Studies
Tolooi N. Association Between Paraoxonase1 (Q192R and L55M) Gene Polymorphisms and Risk of Breast Cancer: A Meta-analysis of 12 Studies. Jentashapir J Cell Mol Biol. 2021;12(4):e121983. doi: https://doi.org/10.5812/jjcmb.121983
The Association between PAI-1 Gene Promoter Polymorphism and Serum Serpin E1, MDA, and Hs-CRP Levels in Coronary Artery Disease
Karimian A, Farajnia S, Ghojazadeh M, Khaki-Khatibi F. The Association between PAI-1 Gene Promoter Polymorphism and Serum Serpin E1, MDA, and Hs-CRP Levels in Coronary Artery Disease. Int Cardiovasc Res J. 2016;10(3):e10176. doi:
- Scopus by DOI: 0
Last Update: 0 months ago
- Scopus by Title: 0
Last Update: 0 months ago
- Scopus by Title (Ref): 0
Last Update: 0 months ago
- CrossRef: 0
Last Update: 1 day ago